SEE Program Strengthens Adherence - Takeaways - MDSpire

SEE Program Strengthens Adherence

Personalized glaucoma coaching program boosts medication adherence and reduces stress in randomized trial

  • By

  • Alun Evans

  • March 4, 2026

  • 3 min

Share

  • 1

    The SEE program significantly improved medication adherence in glaucoma patients compared to standard written education.

  • 2

    Participants in the SEE group achieved a mean adherence of 78%, while controls had 58% adherence by study end.

  • 3

    Over half of SEE participants reached at least 80% adherence, compared to only 24% of control participants.

  • 4

    The SEE intervention also reduced glaucoma-related distress, with participants experiencing a shift from moderate to little distress.

  • 5

    The study highlights the effectiveness of multifaceted, personalized adherence interventions over single-component strategies.

Original Source(s)

SEE Program Strengthens Adherence

  • by Alun Evans

  • March 4, 2026

Related Content

Do Systemic Alpha-2 Agonists Lower Glaucoma Risk?

A large US cohort study found systemic alpha-2 agonist use was associated with a lower hazard of glaucoma-related diagnoses vs. beta-blockers.

Mapping the FLIGHT Path

How incision-free intervention could expand glaucoma treatment options

Cataract and glaucoma surgery in microphthalmic, nanophthalmic, and high hyperopic eyes: a systematic review and meta-analysis